Eintrag weiter verarbeiten
The Genetics of White Matter Lesions
Gespeichert in:
| Zeitschriftentitel: | CNS Neuroscience & Therapeutics |
|---|---|
| Personen und Körperschaften: | , , , , |
| In: | CNS Neuroscience & Therapeutics, 17, 2011, 5, S. 525-540 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Assareh, Arezoo Mather, Karen A. Schofield, Peter R. Kwok, John B.J. Sachdev, Perminder S. Assareh, Arezoo Mather, Karen A. Schofield, Peter R. Kwok, John B.J. Sachdev, Perminder S. |
|---|---|
| author |
Assareh, Arezoo Mather, Karen A. Schofield, Peter R. Kwok, John B.J. Sachdev, Perminder S. |
| spellingShingle |
Assareh, Arezoo Mather, Karen A. Schofield, Peter R. Kwok, John B.J. Sachdev, Perminder S. CNS Neuroscience & Therapeutics The Genetics of White Matter Lesions Pharmacology (medical) Physiology (medical) Psychiatry and Mental health Pharmacology |
| author_sort |
assareh, arezoo |
| spelling |
Assareh, Arezoo Mather, Karen A. Schofield, Peter R. Kwok, John B.J. Sachdev, Perminder S. 1755-5930 1755-5949 Wiley Pharmacology (medical) Physiology (medical) Psychiatry and Mental health Pharmacology http://dx.doi.org/10.1111/j.1755-5949.2010.00181.x <jats:p>White matter lesions (WMLs), commonly seen as hyperintensities on T2‐weighted MRI scans of healthy elderly individuals, are considered to be related to small vessel disease in the brain, and are often associated with subtle cognitive and functional impairments. WMLs also show a strong correlation with a wide range of neurodegenerative and neuropsychiatric disorders. Although a number of vascular risk factors for WMLs have been identified, genetic factors are also important with twin and family studies reporting high heritability. Mutations in several genes have been described that lead to monogenic disorders manifesting WMLs, such as Fabry disease and CADASIL. Because most individuals with WMLs do not have Mendelian disorders, most of the focus has been on single nucleotide polymorphisms as genetic risk markers for WMLs, either directly or through their interactions with other genes or medical risk factors. Candidate genes examined to date include those involved in cholesterol regulation and atherosclerosis, hypertension, neuronal repair, homocysteine levels, and oxidative stress pathways. In addition, although there have been a few genome‐wide linkage studies, only one genome‐wide association study has been performed. The majority of the genetic findings need independent replication, and studies need to be extended to other candidate genes. Collaborative efforts to examine genome‐wide associations in large samples of both sexes of a broad age range using longitudinal studies are necessary. The identification of individuals genetically at risk of developing white matter lesions will have important implications for recognizing the etiology of WMLs and thereby developing clinical intervention strategies for their prevention.</jats:p> The Genetics of White Matter Lesions CNS Neuroscience & Therapeutics |
| doi_str_mv |
10.1111/j.1755-5949.2010.00181.x |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Psychologie Chemie und Pharmazie Biologie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE3NTUtNTk0OS4yMDEwLjAwMTgxLng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE3NTUtNTk0OS4yMDEwLjAwMTgxLng |
| institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
| imprint |
Wiley, 2011 |
| imprint_str_mv |
Wiley, 2011 |
| issn |
1755-5930 1755-5949 |
| issn_str_mv |
1755-5930 1755-5949 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
assareh2011thegeneticsofwhitematterlesions |
| publishDateSort |
2011 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
CNS Neuroscience & Therapeutics |
| source_id |
49 |
| title |
The Genetics of White Matter Lesions |
| title_unstemmed |
The Genetics of White Matter Lesions |
| title_full |
The Genetics of White Matter Lesions |
| title_fullStr |
The Genetics of White Matter Lesions |
| title_full_unstemmed |
The Genetics of White Matter Lesions |
| title_short |
The Genetics of White Matter Lesions |
| title_sort |
the genetics of white matter lesions |
| topic |
Pharmacology (medical) Physiology (medical) Psychiatry and Mental health Pharmacology |
| url |
http://dx.doi.org/10.1111/j.1755-5949.2010.00181.x |
| publishDate |
2011 |
| physical |
525-540 |
| description |
<jats:p>White matter lesions (WMLs), commonly seen as hyperintensities on T2‐weighted MRI scans of healthy elderly individuals, are considered to be related to small vessel disease in the brain, and are often associated with subtle cognitive and functional impairments. WMLs also show a strong correlation with a wide range of neurodegenerative and neuropsychiatric disorders. Although a number of vascular risk factors for WMLs have been identified, genetic factors are also important with twin and family studies reporting high heritability. Mutations in several genes have been described that lead to monogenic disorders manifesting WMLs, such as Fabry disease and CADASIL. Because most individuals with WMLs do not have Mendelian disorders, most of the focus has been on single nucleotide polymorphisms as genetic risk markers for WMLs, either directly or through their interactions with other genes or medical risk factors. Candidate genes examined to date include those involved in cholesterol regulation and atherosclerosis, hypertension, neuronal repair, homocysteine levels, and oxidative stress pathways. In addition, although there have been a few genome‐wide linkage studies, only one genome‐wide association study has been performed. The majority of the genetic findings need independent replication, and studies need to be extended to other candidate genes. Collaborative efforts to examine genome‐wide associations in large samples of both sexes of a broad age range using longitudinal studies are necessary. The identification of individuals genetically at risk of developing white matter lesions will have important implications for recognizing the etiology of WMLs and thereby developing clinical intervention strategies for their prevention.</jats:p> |
| container_issue |
5 |
| container_start_page |
525 |
| container_title |
CNS Neuroscience & Therapeutics |
| container_volume |
17 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792346426721697802 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:38:55.362Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+Genetics+of+White+Matter+Lesions&rft.date=2011-10-01&genre=article&issn=1755-5949&volume=17&issue=5&spage=525&epage=540&pages=525-540&jtitle=CNS+Neuroscience+%26+Therapeutics&atitle=The+Genetics+of+White+Matter+Lesions&aulast=Sachdev&aufirst=Perminder+S.&rft_id=info%3Adoi%2F10.1111%2Fj.1755-5949.2010.00181.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792346426721697802 |
| author | Assareh, Arezoo, Mather, Karen A., Schofield, Peter R., Kwok, John B.J., Sachdev, Perminder S. |
| author_facet | Assareh, Arezoo, Mather, Karen A., Schofield, Peter R., Kwok, John B.J., Sachdev, Perminder S., Assareh, Arezoo, Mather, Karen A., Schofield, Peter R., Kwok, John B.J., Sachdev, Perminder S. |
| author_sort | assareh, arezoo |
| container_issue | 5 |
| container_start_page | 525 |
| container_title | CNS Neuroscience & Therapeutics |
| container_volume | 17 |
| description | <jats:p>White matter lesions (WMLs), commonly seen as hyperintensities on T2‐weighted MRI scans of healthy elderly individuals, are considered to be related to small vessel disease in the brain, and are often associated with subtle cognitive and functional impairments. WMLs also show a strong correlation with a wide range of neurodegenerative and neuropsychiatric disorders. Although a number of vascular risk factors for WMLs have been identified, genetic factors are also important with twin and family studies reporting high heritability. Mutations in several genes have been described that lead to monogenic disorders manifesting WMLs, such as Fabry disease and CADASIL. Because most individuals with WMLs do not have Mendelian disorders, most of the focus has been on single nucleotide polymorphisms as genetic risk markers for WMLs, either directly or through their interactions with other genes or medical risk factors. Candidate genes examined to date include those involved in cholesterol regulation and atherosclerosis, hypertension, neuronal repair, homocysteine levels, and oxidative stress pathways. In addition, although there have been a few genome‐wide linkage studies, only one genome‐wide association study has been performed. The majority of the genetic findings need independent replication, and studies need to be extended to other candidate genes. Collaborative efforts to examine genome‐wide associations in large samples of both sexes of a broad age range using longitudinal studies are necessary. The identification of individuals genetically at risk of developing white matter lesions will have important implications for recognizing the etiology of WMLs and thereby developing clinical intervention strategies for their prevention.</jats:p> |
| doi_str_mv | 10.1111/j.1755-5949.2010.00181.x |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Psychologie, Chemie und Pharmazie, Biologie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE3NTUtNTk0OS4yMDEwLjAwMTgxLng |
| imprint | Wiley, 2011 |
| imprint_str_mv | Wiley, 2011 |
| institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
| issn | 1755-5930, 1755-5949 |
| issn_str_mv | 1755-5930, 1755-5949 |
| language | English |
| last_indexed | 2024-03-01T17:38:55.362Z |
| match_str | assareh2011thegeneticsofwhitematterlesions |
| mega_collection | Wiley (CrossRef) |
| physical | 525-540 |
| publishDate | 2011 |
| publishDateSort | 2011 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | CNS Neuroscience & Therapeutics |
| source_id | 49 |
| spelling | Assareh, Arezoo Mather, Karen A. Schofield, Peter R. Kwok, John B.J. Sachdev, Perminder S. 1755-5930 1755-5949 Wiley Pharmacology (medical) Physiology (medical) Psychiatry and Mental health Pharmacology http://dx.doi.org/10.1111/j.1755-5949.2010.00181.x <jats:p>White matter lesions (WMLs), commonly seen as hyperintensities on T2‐weighted MRI scans of healthy elderly individuals, are considered to be related to small vessel disease in the brain, and are often associated with subtle cognitive and functional impairments. WMLs also show a strong correlation with a wide range of neurodegenerative and neuropsychiatric disorders. Although a number of vascular risk factors for WMLs have been identified, genetic factors are also important with twin and family studies reporting high heritability. Mutations in several genes have been described that lead to monogenic disorders manifesting WMLs, such as Fabry disease and CADASIL. Because most individuals with WMLs do not have Mendelian disorders, most of the focus has been on single nucleotide polymorphisms as genetic risk markers for WMLs, either directly or through their interactions with other genes or medical risk factors. Candidate genes examined to date include those involved in cholesterol regulation and atherosclerosis, hypertension, neuronal repair, homocysteine levels, and oxidative stress pathways. In addition, although there have been a few genome‐wide linkage studies, only one genome‐wide association study has been performed. The majority of the genetic findings need independent replication, and studies need to be extended to other candidate genes. Collaborative efforts to examine genome‐wide associations in large samples of both sexes of a broad age range using longitudinal studies are necessary. The identification of individuals genetically at risk of developing white matter lesions will have important implications for recognizing the etiology of WMLs and thereby developing clinical intervention strategies for their prevention.</jats:p> The Genetics of White Matter Lesions CNS Neuroscience & Therapeutics |
| spellingShingle | Assareh, Arezoo, Mather, Karen A., Schofield, Peter R., Kwok, John B.J., Sachdev, Perminder S., CNS Neuroscience & Therapeutics, The Genetics of White Matter Lesions, Pharmacology (medical), Physiology (medical), Psychiatry and Mental health, Pharmacology |
| title | The Genetics of White Matter Lesions |
| title_full | The Genetics of White Matter Lesions |
| title_fullStr | The Genetics of White Matter Lesions |
| title_full_unstemmed | The Genetics of White Matter Lesions |
| title_short | The Genetics of White Matter Lesions |
| title_sort | the genetics of white matter lesions |
| title_unstemmed | The Genetics of White Matter Lesions |
| topic | Pharmacology (medical), Physiology (medical), Psychiatry and Mental health, Pharmacology |
| url | http://dx.doi.org/10.1111/j.1755-5949.2010.00181.x |